The law firm of Baum Hedlund filed a lawsuit against GlaxoSmithKline, the maker of the antidepressant, Paxil, for causing severe heart defects in the newborn son, of a woman prescribed Paxil during her pregnancy.
Antidepressants involved in three suicides: 19-year old Chess Prodigy; 50-year old lawyer; 11-year old child
Today’s New York Times editorial hits the mark–it’s right on target!
The New York Times reports that a Maryland psychiatrist, Dr. Peter Gleason, was handcuffed and arrested in March and charged with criminal promotion of a drug "for purposes other than those approved by the federal government."
The Greatest Benefit to Mankind: A Medical History of Humanity from Antiquity to the Present , by Professor Roy Porter , Fontana, Press , 1997. Below are a few–still very relevant–quotes…
Bloomberg News reports (below) that Senator Charles Grassley has asked the Inspector General to investigate collusion between FDA officials and Merck. Citing handwritten notes prepared by a Merck executive document a meeting with FDA division director, Brian Harvey, suggesting a joint effort "to get the message out" to discredit Dr….
The Associated Press reports (1, 2 below) that the FDA has just issued new warnings about two additional life-threatening risks induced by SSRI antidepressants: Serotonin Syndrome and Persistent Pulmonary Hypertension in newborn babies.
The Wall Street Journal and Bloomberg News report about a case involving Neuropsychopharmacology, the official journal of the American College of Neuropsychopharmacology (ACNP) that will likely go down in history as psychiatry’s Watergate.
New Peer-Reviewed Publication Authored By Leading Scientists Provides Comprehensive Review of VNS Therapy Mechanism of Action in Treatment-Resistant Depression
CYBERONICS ANNOUNCES MECHANISM OF ACTION ADVISORY BOARD
Operating like thieves under the cover of darkness, prominent academic-based "authorities" in medical specialties have debased academic standards and sold their reputations for cash-
The latest investigative report focusing on financial conflicts of interest by Pulitzer Prize winner, David Willman of the Los Angeles Times, reveals that even as the NIH director, Dr. Elias Zerhouni, announced publicly last year that scientists at the National Institutes of Health would be barred from accepting consulting fees from industry, evidence shows that the ban is clearly not being enforced.
